美股市场个股详情

HALO 奥洛兹美医疗

添加自选

38.570
+0.110+0.29%

收盘价 04/26 16:00 (美东)

37.130
-1.440-3.73%

盘后 19:49 (美东)

49.00亿总市值18.37市盈率TTM

奥洛兹美医疗股票讨论区

登录发表评论

Moomoo AI

02/19 19:59

EPS growth outshines yearly share price gain, hinting at cautious market sentiment. Despite recent sell-off, long-term investors see 16% annual return over five years, suggesting sell-off may be an opportunity for those seeking long-term growth.

Halozyme Therapeutics' (NASDAQ:HALO) Investors Will Be Pleased With Their Impressive 107% Return Over the Last Five Years

Moomoo AI

2023/12/25 19:09

The insider stock selling at Halozyme Therapeutics could raise concerns among shareholders. However, the fact that insiders maintain a considerable amount of shares might suggest some level of alignment between management and smaller shareholders.

Halozyme Therapeutics Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution

Moomoo AI

2023/11/28 18:48

Confidence in Halozyme Therapeutics is suggested due to solid EPS growth and significant insider investment aligning with shareholders' interests.

Should You Be Adding Halozyme Therapeutics (NASDAQ:HALO) To Your Watchlist Today?

逍遥投资派

2023/01/15 23:33

$奥洛兹美医疗(HALO.US)$营收2018年大跌一半至1.5亿，之后三年快速增长到4.4亿，营业利润则是在2020年扭亏达到1.4亿，2021年达到2.8亿，净利润2020年达到1.3亿，2021年达到4亿。
2022前三季度营收增长40%达到4.8亿，但由于费用的大幅增长，营业利润反而下滑12%，净利润下滑57%到1.44亿。
目前市盈率18.4，市盈率TTM已经达到了34，看起来全年结果也不会太好，目前没有吸引力。

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度